SH
Srinivas Hariharan
About Srinivas Hariharan
Data last updated:
Srinivas Hariharan is a Director at Okasa Pharma Private Limited (since 2002), Director at Healingcross Pharma Private Limited (since 2016) and Director at Uni World Pharma Private Limited (since 2006). The companies operate in Metals and Minerals, Pharma and Chemicals. The 3 current companies with reported revenue have a combined latest revenue of ₹25.10 Cr; the largest is Okasa Pharma Private Limited at ₹24.97 Cr (FY 2025). Earlier, Srinivas Hariharan was a Director at Synergy Medicines Private Limited (2006–2023) and Director at Exind Trading Private Limited (2005–2020) and 47 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Okasa Pharma Private Limited U24239MH1990PTC071153 | Director | 04 Sep 2002 | 1990 | ₹24.97 Cr (FY 2025) | Active |
| Healingcross Pharma Private Limited U24239MH2000PTC123771 | Director | 21 Mar 2016 | 2000 | ₹10.7 Lakh (FY 2025) | Active |
| Uni World Pharma Private Limited U24239MH2000PTC130004 | Director | 01 Mar 2006 | 2000 | ₹2.6 Lakh (FY 2024) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Synergy Medicines Private Limited U24230MH2005PTC153054 | Director | 13 Jan 2006 | 2005 | ₹20.5 Lakh (FY 2025) | Active |
| Exind Trading Private Limited U51909MH2004PTC149452 | Director | 01 Feb 2005 | 2004 | ₹7.8 Lakh (FY 2017) | Converted To Llp |
| Respair Technologies India Private Limited U24240MH2000PTC129213 | Director | 01 Mar 2006 | 2000 | Converted To Llp | |
| Mediorals Laboratories Private Limited U24110MH1985PTC037675 | Director | 04 Nov 2011 | 1985 | ₹17.5 Lakh (FY 2016) | Converted To Llp |
| Famid Sports Private Limited U92100MH2008PTC189174 | Director | 26 Dec 2008 | 2008 | ₹7.8 Lakh (FY 2017) | Active |
| One World Pharma Private Limited U24239MH2000PTC130017 | Director | 15 Jul 2010 | 2000 | ₹5.1 Lakh (FY 2018) | Converted To Llp |
 L'amar Natural Product Private Limited U24200MH1995PTC089122 | Director | 04 Sep 2002 | 1995 | ₹5.48 Cr (FY 2025) | Active |
| L'amar Healthcarre Private Limited U74900MH2010PTC202951 | Director | 10 May 2010 | 2010 | ₹2.09 Cr (FY 2025) | Active |
| One World Pharma Llp AAN-6813 | Designated Partner | 10 Dec 2018 | 2018 | Strike Off | |
| Mediorals Laboratories Llp AAI-5407 | Designated Partner | 12 Feb 2017 | 2017 | Strike Off | |
| Floral Fantasy Private Limited U01111MH1995PTC094271 | Director | 22 Jan 2007 | 1995 | Converted To Llp | |
| Cipla Global Limited U24100MH2008PLC187824 | Director | 04 Nov 2011 | 2008 | Strike Off | |
| Protec Laboratories Pvt Ltd U24200MH1986PTC040705 | Director | 04 Sep 2002 | 1986 | Strike Off | |
| Medex Specialities Private Limited U24230MH1988PTC047035 | Director | 04 Nov 2011 | 1988 | Converted To Llp | |
| Lancet Pharma Private Limited U24230MH2000PTC126038 | Director | 04 Sep 2002 | 2000 | Converted To Llp | |
| Nebumed Pharma Private Limited U24230MH2000PTC125579 | Additional Director | 30 Apr 2015 | 2000 | Converted To Llp |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Srinivas Hariharan
| Name | DIN | Company | Designation |
|---|---|---|---|
| Raman Parameswaran Athipotta | 00025481 | Okasa Pharma Private Limited | Director |
| Shankar Srinivasan | 02712026 | Healingcross Pharma Private Limited , Uni World Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Srinivas Hariharan
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Srinivas Hariharan
Srinivas Hariharan currently holds 3 directorships: Okasa Pharma Private Limited (Director, since 04 Sep 2002, revenue ₹24.97 Cr (FY 2025)); Healingcross Pharma Private Limited (Director, since 21 Mar 2016, revenue ₹10.7 Lakh (FY 2025)); Uni World Pharma Private Limited (Director, since 01 Mar 2006, revenue ₹2.6 Lakh (FY 2024)).
Srinivas Hariharan was first appointed on 04 Sep 2002 as Director at Okasa Pharma Private Limited. The most recent appointment on record is 10 Dec 2018 at One World Pharma Llp.
The 3 current companies of Srinivas Hariharan that report revenue have a combined latest revenue of ₹25.10 Cr: Okasa Pharma Private Limited ₹24.97 Cr (FY 2025); Healingcross Pharma Private Limited ₹10.7 Lakh (FY 2025); Uni World Pharma Private Limited ₹2.6 Lakh (FY 2024).
Srinivas Hariharan held 49 earlier board appointments: Synergy Medicines Private Limited (Director, 13 Jan 2006 to 11 Aug 2023); Exind Trading Private Limited (Director, 01 Feb 2005 to 27 Feb 2020); Respair Technologies India Private Limited (Director, 01 Mar 2006 to 02 May 2007); Mediorals Laboratories Private Limited (Director, 04 Nov 2011 to 11 Feb 2017); Famid Sports Private Limited (Director, 26 Dec 2008 to 04 Aug 2009); and 44 more.
The current boards of Srinivas Hariharan's companies include Raman Parameswaran Athipotta (Okasa Pharma Private Limited), Shankar Srinivasan (Healingcross Pharma Private Limited).